Physician profile
Corrin Rodriguez
NPI 1861150617
$2,620.21
in general payments reported to CMS, 2019-2025
15 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what 81% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $653 · 2023: $653 · 2024: $293 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,967.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $614.89 | 2022-2025 | |
| Axsome Therapeutics, INC. | $468.33 | 2022-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $387.94 | 2022-2025 | Rexulti, Abilify Asimtufii, Nuedexta |
| Janssen Pharmaceuticals, INC | $179.25 | 2022-2025 | Spravato, Invega, Invega Trinza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $175.10 | 2022-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $170.11 | 2022-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Neurocrine Biosciences, INC. | $145.85 | 2022-2025 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $127.50 | 2025 | Cobenfy |
| Takeda Pharmaceuticals U.S.A., INC. | $76.38 | 2022-2023 | Trintellix |
| Lundbeck LLC | $69.75 | 2023-2024 | Rexulti |
| Corium, LLC | $56.36 | 2023-2025 | Azstarys |
| Alkermes, INC. | $48.61 | 2022-2023 | Aristada, Lybalvi |
| Supernus Pharmaceuticals, INC. | $43.25 | 2023-2024 | Qelbree, Qelbree |
| Vanda Pharmaceuticals INC. | $39.74 | 2025 | Fanapt |
| Idorsia Pharmaceuticals US INC | $17.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corrin Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.